News
Marga Frontera, new scientific office manager at IDIBELL
On April 2nd Marga Frontera joined IDIBELL as scientific office manager. Her mission, in her own words, is “getting the researcher, as far as possible, do not worry about anything but to investigate”. Frontera knows the day-to-day work in the laboratory because she has worked as a postdoctoral researcher in the laboratory of genomic imprinting […]
Nicolás Manito: ”the new mechanical hearts save transplants”
Heart failure is the leading cause of admission to hospital and one of the health problems that is growing as people live longer. The head of the Heart Failure and Cardiac Transplant Unit at the Bellvitge University Hospital and researcher at the Cardiovascular Diseases group at IDIBELL, Nicolás Manito, spoke about heart failure on May […]
The neuroscientist Josef Rauschecker explains at CosmoCaixa the evolution of speech and music: from apes to humans
Rauschecker leads the integrated neuroscience laboratory and Cognition at the University of Georgetown. His research focuses on understanding the neurophysiological mechanisms that differentiate us from other primate species and that have allowed us to develop throughout the evolution of music and speech. In this talk we will know the neural circuits in humans and monkeys […]
Manel Esteller, BIAL Foundation Distinction for his work in cancer genetics
Manel Esteller, Director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with a BIAL Foundation Distinction in its eighth edition. The international honour distinguishes a research work which content constitutes a significant contribution in the field of Health Sciences. […]
Diego Viasus awarded the Extraordinary Doctorate Prize of the Faculty of Medicine of the UB
The PhD thesis of Diego Viasus researcher at Infections of the respiratory tract and in Immunocomproimised Patients research group at IDIBELL has won two awards. On one hand, has received the Extraordinary Doctorate Award from the Faculty of Medicine of the University of Barcelona and on the other, the Gabriel Rufí Prize for the best […]
José Luis Hernández: ”We have designed two antibodies that block S100 proteins and we’ve observed that slow tumors growth”
The laboratory of José Luis Hernández at the Biomed division, LEITAT Technology Center of Barcelona works in the clinical application of two antibodies designed by them to block proliferative function of extracellular S100 proteins. Hernandez explained his research on April 26 at a conference framed at IDIBELL seminars cycle. “We designed two antibodies that block […]
IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease
IDIBELL has signed a licensing agreement with the Catalan biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease, which has no effective treatment. The Neurometabolic Diseases group led by ICREA researcher Aurora Pujol, has developed an animal model to study this disease. Studies using this model have […]
‘Dark genome’ is involved in Rett Syndrome
Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding long chain RNA sequences (lncRNA) in Rett syndrome. These molecules act as supervisor agents responsible of ‘switch on’ or ‘switch off’ other genes in our […]